Active Ingredient History

NOW
  • Now
Rescinnamine is an alkaloid isolated from Rauvolfia serpentina and approved by FDA for the treatment of hypertension. The mechanism of rescinnamine is not established, but probably resembles that of reserpine. Rescinnamine approval was discontinued by unknown reason.   NCATS

  • SMILES: CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)\C=C\C6=CC(OC)=C(OC)C(OC)=C6
  • InChIKey: SZLZWPPUNLXJEA-QEGASFHISA-N
  • Mol. Mass: 634.716
  • ALogP: 4.57
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral
  • Pro Drug: No
3,4,5-trimethoxycinnamoyl methyl reserpate | cinnaloid | cinnasil | methyl trimethoxycinnamoylreserpate | moderil | rescinnamin | rescinnamine | rescisan | resealoid | reserpinine | scinnamina | trimethoxy cinnamoyl reserpate de methyl | tsuruselpi s | yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue